Preferences help
enabled [disable] Abstract
Number of results
2003 | 50 | 4 | 1175-1185
Article title

A study of the influence of newly synthesized acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives on deoxythymidine and deoxycytidine kinase activities in human neurofibrosarcoma and ovarian cancer.

Title variants
Languages of publication
The influence of nine newly synthesized uracil acyclonucleosides, and 36 derivatives of 1,2,3,4-tetrahydroisoquinoline on the activity of enzymes catalysing dTMP and dGMP synthesis, on the content of dTTP and dGTP in acid soluble fraction and on the incorporation of [14C]dThd and [14C ]dGuo into DNA in tumour homogenates was studied. The influence of the compounds was studied in the cytosol from intraoperatively excised human tumours - neurofibrosarcoma and ovarian cancer. It was shown that dTMP and dGMP synthesis is inhibited competitively by 34.1±4.0% in both types of tumours by 0.2 mM 1-N-(3'-hydroxypropyl)-6-methyluracil (1) and 0.2 mM 1-N-(3'-hydroxypropyl)- 5,6- tetramethyleneuracil (2). The mentioned acyclonucleosides reduced the content of dTTP and dGTP in the acid soluble fraction of tumours (59.7±3.1% of control). 1-(4-chlorophenyl)-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (3), 1-(2,3-dichlorophenyl)-6,7-dihydroxy 1,2,3,4-tetrahydroisoquinoline (4) and 1-(3-methoxyphenyl)-6,7-dihydroxy 1,2,3,4-tetrahydroisoquinoline (5) at 0.2 mM concentration caused a mixed type inhibition of the synthesis of dTMP and dGMP by, on average, 33.2±4.4%, and reduced the content of dTTP and dGTP in the acid soluble fraction (52.6±3.7% of control) but were active only in the cytosol of neurofibrosarcoma. While acyclonucleosides undergo phosphorylation in the cytosol by cellular kinases, with their triphosphates being active acyclonucleoside metabolites, active 1,3,4,5-tetrahydroisoquinoline derivatives (compounds not containing a deoxyribose moiety), cannot be phosphorylated. ACN and THI derivatives which inhibit dThd and dCyd kinase activities, inhibit also the incorporation of [14C]dThd and [14C]dGuo (ACN - 50.2±2.7%, THI - 53.4±3.9% of incorporation inhibition) into tumour DNA. The obtained results point to the mechanism of uracil acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline biological activity consisting in inhibiting the synthesis of DNA components.
Physical description
  • Abe K, Taguchi K, Wasai T, Ren J, Utsunomiya I, Shinohara T, Miyatake T, Sano T. (2001) Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline induced parkinsonism in the mouse. Brain Res.; 907: 134-8.
  • Akyoshi H. (1984) Formation of deoxynucleoside 5'-monophosphate dependent on DNA synthesis in nuclei isolated from regenerating rat liver. Biochim Biophys Acta.; 782: 142-6.
  • Anders K, Jensen RB. (1958) Isothiocyanates XXXII. Synthesis and reactions of 3-benzyloxypropyl isothiocyanate, enzymatically liberated from glucomalcolmin and some compounds of related structure. Acta Chem Scand.; 12: 1746-58.
  • Arner ES, Eriksson S. (1995) Mammalian deoxynucleoside kinase. Pharmacol Ther.; 67: 155-186.
  • Blin N, Stafford DW. (1976) General methods for isolation of high molecular DNA from eucariotes. Nucleic Acids Res.; 3: 2303-8.
  • Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem.; 72: 248-54.
  • Brzezińska E. (1996) Synthesis and pharmacological properties of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline. Acta Pol Pharm.; 53: 365-71.
  • Buczyński B, Potter RL. (1990) Nucleoside diphosphate kinase from Xenopus oocytes: partial purification and characterisation. Biochim Biophys Acta.; 1041: 296-304.
  • Daher GC, Harris BE, Diasio R. (1990) Metabolism of pyrimidine analogues and their nucleosides. Pharmacol Ther.; 48: 189-222.
  • Fossey C, Laduerre D, Robba A. (1994) Synthesis of acyclic thiens [3,2-delta] pyrimidine nucleosides and azido derivatives as potential anti-HIV agents. Nucleosides & Nucleotides.; 13: 883-9.
  • Goldbrunner M, Loidl G, Polossek T, Mannschreck A, Auger E. (1997) Inhibition of tubulin polymerization by 5,6-dihydro[21-alpha] isoquinoline derivatives. J Med Chem.; 40: 3524-33.
  • Greger J, Dramiński M. (1989) Growth inhibition of Kirkman-Robbins hepatoma by 1(1',3'-dihydroxy-2'-propoxymethyl)-5,6-tetramethyleneuracil and possible mechanism of its biological activity. Z Naturforsch.; 44c: 985-91.
  • Harnden MR, Parkin A, Parratt MJ, Perkins RM. (1993) Novel acyclonucleosides: synthesis and antiviral activity of alkenylphosphonic acid derivatives of purine and pyrimidine. J Med Chem.; 36: 1343-55.
  • Ilsley DD, Lee S-H, Miller WH, Kuchta RD. (1995) A cyclic guanosine analogs inhibit DNA polymerase α, δ and ε with very different potenties and have unique mechanism of action. Biochemistry.; 34: 2504-10.
  • Jullig M, Eriksson S. (2001) Apoptosis induced efflux of the mitochondrial matrix enzyme deoxyguanosine kinase. J Biol Chem.; 276: 24000-4.
  • Jung Y, Surh Y. (2001) Oxidative DNA damage and cytotoxicity induced copper stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Rad Biol Med.; 30: 1407-17.
  • Kawai H, Kotake Y, Ohta S. (2000) Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of 1-(3',4'-dihydroxybenzyl)-1,2,3,4-tertahydroisoquinoline. Chem Res Toxicol.; 13: 1294-301.
  • Kotera J, Fujishige K, Michibata H, Yuasa K, Kubo A, Nakamura Y, Omori K. (2000) Characterisation and effects on methyl-2-(4-aminophenyl)-1,2-dihydro-1-oxo- 7-(2-pyridynylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate. (T-1032) a novel potent inhibitor of cGMP-binding cGMP specific phosphodiesterase. Biochem Pharm.; 60: 1333-41.
  • Letnansky K. (1964) The influence of 2-deoxy-D-glucose on the nucleotide content of Ehrlich ascites carcinoma cells. Biochim Biophys Acta.; 87: 1-8.
  • Lin M-C, Shun T-S, Penketh P, Sartorelli A. (1995) Synthesis and antitumor activity of 4 and 5 substituted derivatives of isoquinoline-1-carboxyaldehyde-thio-semicarba-sone. J Med Chem.; 38: 4234-45.
  • Modrzejewska H, Greger J, Dramiński M, Rutkowski M. (1996) The influence of alkoxymethyl purine and pyrimidine acyclonucleosides on growth inhibition of Kirkman-Robbins hepatoma and possible mechanism of their cytostatic activity. Z Naturforsch.; 51c: 75-80.
  • Modrzejewska H, Dramiński M, Zgit- Wroblewska A, Greger J. (1999) Further studies on cytostatic activity of alkoxymethyl purine and pyrimidine acyclonucleosides. Z Naturforsch.; 54c: 923-31.
  • Parker WB, Shaddix SC, Rose LM, Taiwari KN, Mongomery JA, Secrist III JA, Benett LL Jr. (1995) Metabolism and metabolic action of 4-thiothymidine in L 1210 cells. Biochem Pharmacol.; 50: 687-95.
  • Rutkowski M, Korczak E. (1992) Biotransformation by Enterobacter agglomerans of pyrimidine acyclonucleosides to acyclonucleotides. Experientia.; 48: 600-3.
  • Usova E, Eriksson S. (1997) The effects of high salt concentration on the regulation of the substrate specificity of human recombinant deoxycytidine kinase. Eur J Biochem.; 248: 762-6.
  • Wang L, Karlsson A, Arner ESJ, Eriksson S. (1993) Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. J Biol Chem.; 268: 22847-52.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.